Home > Insider Trading > Filing (0001181431-15-007002)

Filing Details

Accession Number:: 0001181431-15-007002
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-05-15 17:30:22
Reporting Period:: 2015-05-14

Filing Date:: 2015-05-15
Accepted Time:: 2015-05-15 17:30:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1466301	Clovis Oncology Inc.	CLVS	Pharmaceutical Preparations (2834)	900475355

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1219855	James M Barrett	1954 Greenspring Drive Suite 600 Timonium MD 21093		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-05-14	1,139,891	$0.00	1,139,890	No	4	J	Indirect	See Note 2
Common Stock	Acquisiton	2015-05-14	11,399	$0.00	11,399	No	4	J	Indirect	See Note 4
Common Stock	Disposition	2015-05-14	11,399	$0.00	0	No	4	J	Indirect	See Note 4
Common Stock	Acquisiton	2015-05-14	287	$0.00	574	No	4	J	Direct
Common Stock	Acquisiton	2015-05-14	287	$0.00	574	No	4	J	Indirect	See Note 8
Common Stock	Acquisiton	2015-05-14	2,424	$0.00	2,424	No	4	J	Indirect	See Note 10
Common Stock	Disposition	2015-05-15	500	$91.86	1,924	No	4	S	Indirect	See Note 10
Common Stock	Disposition	2015-05-15	1,924	$92.57	0	No	4	S	Indirect	See Note 10

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Indirect	See Note 2
No	4	J	Indirect	See Note 4
No	4	J	Indirect	See Note 4
No	4	J	Direct
No	4	J	Indirect	See Note 8
No	4	J	Indirect	See Note 10
No	4	S	Indirect	See Note 10
No	4	S	Indirect	See Note 10

Footnotes

New Enterprise Associates 13, L.P. ("NEA 13") made a pro rata distribution for no consideration of an aggregate of 1,139,891 shares of common stock of the Issuer to its general partner and its limited partners on May 14, 2015.
The Reporting Person is a director of NEA 13 GP, LTD, which is the sole general partner of NEA Partners 13, L.P. ("NEA Partners 13"). NEA Partners 13 is the sole general partner of NEA 13, the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the shares held by NEA 13, except to the extent of his pecuniary interest therein.
NEA Partners 13 received 11,399 shares of common stock of the Issuer in the distribution by NEA 13 on May 14, 2015.
The Reporting Person is a director of NEA 13 GP, LTD, which is the sole general partner of NEA Partners 13. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the shares held by NEA Partners 13, except to the extent of his pecuniary interest therein.
NEA Partners 13 made a pro rata distribution for no consideration of an aggregate of 11,399 shares of common stock of the Issuer to its limited partners on May 14, 2015.
M. James Barrett and April Barrett received 287 shares of common stock of the Issuer in the distribution by NEA Partners 13 on May 14, 2015.
Barrett 2006 Family Trust received 287 shares of common stock of the Issuer in the distribution by NEA Partners 13 on May 14, 2015.
The securities are directly held by the Barrett 2006 Family Trust. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities of the Issuer held by the Barrett 2006 Family Trust in which the Reporting Person has no pecuniary interest.
New Enterprise Associates, LLC ("NEA LLC") received 2,424 shares of common stock of the Issuer in the distribution by NEA Partners 13 on May 14, 2015.
The Reporting Person is a member of the Board of Directors of NEA LLC, which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the 1934 Act, as amended, or otherwise of the shares held by NEA LLC, except to the extent of his pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.76 to $92.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (11) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.15 to $93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (12) to this Form 4.